首页> 美国卫生研究院文献>Clinical Molecular Pathology >Immunoperoxidase labelled antibody staining in differential diagnosis of central nervous system haemangioblastomas and central nervous system metastases of renal carcinomas.
【2h】

Immunoperoxidase labelled antibody staining in differential diagnosis of central nervous system haemangioblastomas and central nervous system metastases of renal carcinomas.

机译:免疫过氧化物酶标记的抗体染色可鉴别诊断中枢神经系统血管母细胞瘤和肾癌的中枢神经系统转移。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The problem of the differential diagnosis both of central nervous system haemangioblastomas and metastases of renal clear cell carcinomas was investigated by immunoperoxidase labelled antibody staining of five cases each of haemangioblastoma and metastatic renal carcinoma. Staining using anticarcinoembryonic antigen (CEA), antikeratin, antifactor VIII related antigen, and antibrush border was unhelpful. All five of the haemangioblastomas were negative and all five of the metastases were positive for epithelial membrane antigen (EMA), as defined by immunoperoxidase staining. This shows that commercially available anti-EMA monoclonal antibody is useful in distinguishing the two pathological entities.
机译:通过免疫过氧化物酶标记的抗体染色法分别对5例血管母细胞瘤和转移性肾癌患者进行中枢神经系统血管母细胞瘤和肾透明细胞癌转移的鉴别诊断问题。使用抗癌胚抗原(CEA),抗角蛋白,抗VIII因子相关抗原和抗刷边界染色无济于事。根据免疫过氧化物酶染色的定义,所有五个血管母细胞瘤均为阴性,所有五个转移瘤均为上皮膜抗原(EMA)阳性。这表明可商购的抗EMA单克隆抗体可用于区分两种病理实体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号